FDA OKs Pfizer drug for rare type of leukemia

By Linda A. Johnson
The Associated Press
BUSINESS

TRENTON, N.J. » The Food and Drug Administration has approved a new medicine for use against a rare, rapidly progressing blood cancer after other treatments have failed. The agency approved Pfizer Inc.’s Besponsa for patients with a type of advanced...

Read latest The Middletown Press (Middletown, CT) online.

Online newspapers at PressDisplay. Newspapers from United States
Newspapers in English